ASCO Annual Meeting

Immigrant Cancer Survivors Face Higher Rates of Uninsurance, Financial Hardship, Food Insecurity

July 2nd 2023, 5:00pm

Article

Immigrant and foreign-born cancer survivors experience several disparities that suggest barriers to care and “may portent worse health outcomes in cancer survivorship,” according to researchers.

Lacking Emotional Support May Impact Quality of Life in Older Patients With GI Cancers

July 1st 2023, 6:00pm

Article

Patients 60 years and older with gastrointestinal cancers who reported inadequate emotional support were more likely to have poorer physical and mental quality of life, although no effect was observed in overall survival.

‘Reassuring’ Findings Show That Flu Shot Is Safe During Immunotherapy

June 30th 2023, 8:00pm

Article

Patients with cancer undergoing immunotherapy treatment did not have increased hospitalizations or serious side effects after getting the flu shot.

Calquence and Brukinsa Have Similar Relapsed/Refractory CLL Outcomes

June 25th 2023, 5:00pm

Article

There was no major difference in progression-free survival between patients with relapsed/refractory chronic lymphocytic leukemia who were treated with Calquence or Brukinsa.

‘There’s a Lot of Innovation’ in the KRAS-Mutant Lung Cancer Space

June 20th 2023, 3:00pm

Video

An expert discusses the ongoing SPARK trial for KRASG12-mutant non-small cell lung cancer, and what she hopes for the future of this patient population.

Study Shows ‘A Lot of Hope’ for Prostate Cancer Treatment

June 15th 2023, 9:00pm

Video

Most patients with nonmetastatic castration-resistant prostate cancer were able to stay on their therapies long-term, research showed.

ctDNA May Help Predict Lung Cancer Outcomes, Guide Treatment

June 7th 2023, 3:00pm

Video

Patients with non-small cell lung cancer who cleared 50% or more of cancerous DNA from their blood by their fourth treatment cycle tended to have better outcomes on maintenance therapy, research showed.

Maintenance Zejula Induces Antitumor Activity, Increases Survival in Advanced Ovarian Cancer

June 7th 2023, 1:00pm

Article

Meaningful improvements in survival were obtained with Zejula maintenance therapy compared with placebo in patients with advanced ovarian cancer that was newly diagnosed.

Tumor Treating Fields With Standard of Care May Significantly Improve Survival in Metastatic NSCLC

June 6th 2023, 10:00pm

Article

Tumor treating fields therapy “is a potentially paradigm-shifting new treatment modality” for metastatic non-small cell lung cancer, says Dr. Ticiana Leal.

Adding Opdivo to Chemo May Prolong Survival in Advanced Hodgkin Lymphoma

June 6th 2023, 8:00pm

Article

Patients with advanced-stage classic Hodgkin lymphoma had a longer progression-free survival rate with Opdivo plus AVD, a chemotherapy regimen, compared with Adcetris plus AVD.